4th Quarter - Report

FABIANI & COMPANY for REGENESIS BIOMEDICAL

Period 4th Quarter 2011 Filed Jan 19, 2012 Signed by Gary Martin, CFO

Official filing
Firm
FABIANI & COMPANY
Client
REGENESIS BIOMEDICAL
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Educate Members of Congress and staff on Regenesis issues as a small business and innovator in the biomedical sector. Seek information from agencies regarding opportunities for federal funding, partnerships, and sales.

LobbyistCovered position, as disclosed
RAVI SAWHNEY —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Defense, Dept of (DOD)

Medicare/Medicaid MMM

Educate Members of Congress and staff on Regenesis issues as a small business and innovator in the biomedical sector. Seek information from agencies regarding opportunities for federal funding, partnerships, and sales.

LobbyistCovered position, as disclosed
RAVI SAWHNEY —

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE; Natl Institutes of Health (NIH)

Science/Technology SCI

Educate Members of Congress and staff on Regenesis issues as a small business and innovator in the biomedical sector. Seek information from agencies regarding opportunities for federal funding, partnerships, and sales.

LobbyistCovered position, as disclosed
RAVI SAWHNEY —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Defense, Dept of (DOD); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.